Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
SAI Life Sciences Ltd. ( (IN:SAILIFE) ) has provided an announcement.
Sai Life Sciences Ltd. has submitted a certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended March 31, 2025. This submission, certified by KFin Technologies Limited, confirms that the details of securities dematerialized or rematerialized during this period have been furnished to all stock exchanges where the company’s shares are listed, ensuring compliance with regulatory requirements.
More about SAI Life Sciences Ltd.
Sai Life Sciences Ltd. operates in the life sciences industry, focusing on providing contract research, development, and manufacturing services to pharmaceutical and biotechnology companies. The company’s market focus includes supporting drug discovery, development, and manufacturing processes.
YTD Price Performance: -15.53%
Average Trading Volume: 18,536
See more data about SAILIFE stock on TipRanks’ Stock Analysis page.